Home › Essential Thrombocythemia › California › Los Angeles
Essential Thrombocythemia clinical trials in Los Angeles, CA
3 studies for Essential Thrombocythemia are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
RecruitingPhase 3
- University of California, Los Angeles Medical Center, Los Angeles
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
RecruitingPhase 1
- Usc Norris Comprehensive Cancer Center, Los Angeles
- UCLA Medical Hematology & Oncology, Los Angeles
Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms
RecruitingPhase 2
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
Essential Thrombocythemia trials in other cities
- New York City, NY7 studies
- Durham, NC6 studies
- Chicago, IL4 studies
- Boston, MA4 studies
- Baltimore, MD4 studies
- Mountain View, CA4 studies
- Nashville, TN4 studies
- Miami, FL4 studies
- Salt Lake City, UT4 studies
- Irvine, CA3 studies
- Cleveland, OH3 studies
- St. Louis, MO3 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)74 studies
- Breast Cancer73 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer50 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer35 studies
- Endometrial Cancer34 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.